Received Oct 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | 49M9N | — |
gave Bexsero vaccine to a child 6 years old, Intention was to administered (Engerix-B) hepatits B; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 6-year-old female patient who received Men B NVS (Bexsero) (batch number 49M9N, expiry date 29-FEB-2028) for prophylaxis. Co-suspect products included HBV (Engerix B) for prophylaxis. On 18-SEP-2025, the patient received the 1st dose of Bexsero. The patient did not receive Engerix B. On 18-SEP-2025, an unknown time after receiving Bexsero, the patient experienced wrong vaccine administered (Verbatim: gave Bexsero vaccine to a child 6 years old, Intention was to administered (Engerix-B) hepatits B). The outcome of the wrong vaccine administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 18-SEP-2025 A medical assistant had given an incorrect vaccine to a child who was 6 years old. Instead of Engerix-B (Hepatitis B), which was intended as the first dose, the child had received Bexsero. They had wanted to know what to monitor following the administration. The child was due to turn 6 in October.